Introduction：Basic information about CAS 595566-61-3|pagibaximab, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | pagibaximab |
|---|
| CAS Number | 595566-61-3 | Molecular Weight | / |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | / | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
pagibaximab BiologicalActivity
| Description | Pagibaximab is a chimeric IgG1 antibody recognizing the surface component lipoteichoic acid of S. aureus and S. epidermidis. Pagibaximab can be used to prevent staphylococcal sepsis[1]. |
|---|
| Related Catalog | Research Areas >>InfectionSignaling Pathways >>Anti-infection >>Bacterial |
|---|
| Target | S. epidermidis lipoteichoic acid[1] |
|---|
| References | [1]. Weisman LE, et, al. A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis. Pediatrics. 2011 Aug;128(2):271-9. |
|---|
Chemical & Physical Properties
| No Any Chemical & Physical Properties |
